Applied Therapeutics (APLT) Downgraded by Zacks Investment Research to Hold

Applied Therapeutics stock has undergone multiple analysts rating changes in the recent past.  Applied Therapeutics Downgraded by Zacks Investment Research on 10/13/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Buy.

Shares of Applied Therapeutics traded up $1.41 on Wednesday, reaching $18.29. 125172 shares of the stock traded hands, compared to its average volume of 95101. Shares of Applied Therapeutics were trading at $18.29 on Wednesday. The firm’s 50 day moving average is $16.12 and its 200 day moving average is $19.15.Applied Therapeutics has a 12 month low of $16.85 and a 12 month high of $29.80. While on yearly highs and lows, Applied Therapeutics’s today has traded high as $18.49 and has touched $16.85 on the downward trend. See More Analyst Rating at: RATING

Applied Therapeutics Earnings and What to expect: 

Applied Therapeutics last posted its quarterly earnings results on August 11th, 2021. The reported ($0.99) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.13) by $0.14. Applied Therapeutics has generated ($4.28) earnings per share over the last year (($4.38) diluted earnings per share). Earnings for Applied Therapeutics are expected to grow in the coming year, from ($4.20) to ($3.58) per share. Applied Therapeutics has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, November 11th, 2021 based off prior year’s report dates.

Earnings for Applied Therapeutics are expected to grow in the coming year, from ($4.20) to ($3.58) per share. The P/E ratio of Applied Therapeutics is -4.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Applied Therapeutics is -4.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Applied Therapeutics has a P/B Ratio of 5.02. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Applied Therapeutics (APLT) Moving Average Technical Analysis

5 day Moving Average is $17.15 And 5 day price change is $2.14 (13.25%)  with average volume for 5 day average is 67,500. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $16.08 and 20 day price change is $3.44 (23.16%) and average 20 day moving volume is 106,635. 50 day moving average is $16.12  and 50 day price change is $0.18 ( 0.99%)  and with average volume for 50 days is : 97,886. 200 day moving average is $19.15  and 200 day price change is -$3.98 (-17.87%)  and with average volume for 200 days is : 105,302.

Other owners latest trading in Applied Therapeutics :

  • On 8/17/2021 shares held by Knoll Capital Management LLC were 1,032,123 which equates to market value of $21.45M and appx 11.20% owners of Applied Therapeutics
  • On 8/17/2021 shares held by Metropolitan Life Insurance Co NY were 5,405 which equates to market value of $0.11M and appx 0.00% owners of Applied Therapeutics
  • On 8/17/2021 shares held by MetLife Investment Management LLC were 7,129 which equates to market value of $0.15M and appx 0.00% owners of Applied Therapeutics
  • In total Institutional ownership equates to Institutional Ownership Percentage: 58.72% for Applied Therapeutics

See More Analyst Rating at: RATING